Rex Bionics plc, the pioneer of the REX Robot technology that enhances the mobility of wheelchair users and Deltason Medical Ltd, a distributor of rehabilitation equipment in Hong Kong and China, are pleased to announce that they have signed a distribution agreement in which Deltason will exclusively represent REX in Hong Kong, both in neuro-rehabilitation clinics and in the personal use market.
Australia, 27 April 2015.
Read more about Avita Medical Granted CE Mark for Expanded ReCell™
Australia, 23 April 2015.
Cambridge, 21st April 2015 —Published results from a randomized control clinical trial that used Avita Medical’s skin regenerating device to successfully treat chronic wounds have won the lead clinician the ‘Avita Medical...
Avita Medical Ltd. (ASX: AVH ), (OTCQX: AVMXY), a regenerative medicine company specializing in the treatment of wounds and skin defects, today announced the appointment of Mr. Adam Kelliher as Chief Executive Officer.
Read more about Avita Medical Appoints Adam Kelliher as Chief Executive Officer
AmpliPhi BioSciences Corporation. (OTCQB: APHB), the global leader in developing bacteriophage-based antibacterial therapies to treat drug resistant infections, today announced that the European Patent Office (EPO) has granted European patent no. EP 2570130, “Bacteriophage-containing Therapeutic Agents”.
SeaDragon (NZX:SEA) is New Zealand’s largest refiner and blender of high-quality, internationally certified concentrated fish oils and fractions, including Omega-3 oils. Our oils are sourced from fish caught in the clean and pure waters around New Zealand, in the Southern Ocean, and elsewhere.
Read more about SeaDragon Investor Update April 2015
Veterinary biologic therapy developer Nexvet Biopharma (Nasdaq:NVET) today announced it has appointed former Division Head of Novartis Animal Health Dr. George Gunn as non-executive chairman of the Nexvet Board of Directors. The appointment is effective from 31 March 2015.
Read more about Nexvet Biopharma Appoints Dr. George Gunn as Chairman